Etil loflazepat Садржај Osobine Reference Literatura Spoljašnje veze Мени за навигацијуloflazepate.html Monografija29177-84-23299DB015453183CHEMBL1213460„DrugBank 3.0: a comprehensive resource for omics research on drugs”30137092105968210.1093/nar/gkq1126уреди„DrugBank: a knowledgebase for drugs, drug actions and drug targets”22388891804841210.1093/nar/gkm958уреди„Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”10.1021/jp980230o„Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”1174957310.1021/ci000392tуреди„Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”1102028610.1021/jm000942eуредиGoodman & Gilman's The Pharmacological Basis of Therapeutics10.1036/0071422803Foye's Principles of Medicinal ChemistryEtil loflazepatVikimedijinoj ostaviEthyl loflazepate
АнксиолитициКарбоксилатни естриАцетамидиЕтриОрганофлуоридиХлороарениБензодиазепини
organsko jedinjenjeatomaugljenikamolekulsku masuDa
(function()var node=document.getElementById("mw-dismissablenotice-anonplace");if(node)node.outerHTML="u003Cdiv class="mw-dismissable-notice"u003Eu003Cdiv class="mw-dismissable-notice-close"u003E[u003Ca tabindex="0" role="button"u003Eсакријu003C/au003E]u003C/divu003Eu003Cdiv class="mw-dismissable-notice-body"u003Eu003Cdiv id="localNotice" lang="sr" dir="ltr"u003Eu003Cdiv style="position:relative; overflow:hidden; background-color:#5E9DC8; text-align:center; color:white; font-size:1.25em; font-weight:bold; line-height:1.5em; margin-top: 5px;"u003Eu003Cuu003Eu003Ca href="/wiki/%D0%92%D0%B8%D0%BA%D0%B8%D0%BF%D0%B5%D0%B4%D0%B8%D1%98%D0%B0:%D0%A2%D0%B0%D0%BA%D0%BC%D0%B8%D1%87%D0%B5%D1%9A%D0%B5_%D1%83_%D0%BF%D0%B8%D1%81%D0%B0%D1%9A%D1%83_%D1%87%D0%BB%D0%B0%D0%BD%D0%B0%D0%BA%D0%B0/%D0%A6%D0%95%D0%95_%D0%BF%D1%80%D0%BE%D0%BB%D0%B5%D1%9B%D0%B5_2019" title="Википедија:Такмичење у писању чланака/ЦЕЕ пролеће 2019"u003Eu003Cspan style="color:white"u003EТакмичите се у писању чланака о Средњој и Источној Европи од 21. марта до 31. маја!u003C/spanu003Eu003C/au003Eu003C/uu003Eu003C/divu003Enu003Cdiv style="position:relative; overflow:hidden; background-color:#5E9DC8; text-align:center; color:white; font-size:1.25em; font-weight:bold; line-height:1.5em; margin-top: 5px;"u003Eu003Cuu003Eu003Ca href="/wiki/%D0%92%D0%B8%D0%BA%D0%B8%D0%BF%D0%B5%D0%B4%D0%B8%D1%98%D0%B0:%D0%93%D0%BB%D0%B0%D1%81%D0%B0%D1%9A%D0%B5/%D0%94%D0%BE%D0%BF%D1%83%D0%BD%D0%B0_%D0%BF%D1%80%D0%B0%D0%B2%D0%B8%D0%BB%D0%B0_%D0%BE_%D0%B8%D0%B7%D0%B0%D0%B1%D1%80%D0%B0%D0%BD%D0%B8%D0%BC_%D1%81%D0%BB%D0%B8%D0%BA%D0%B0%D0%BC%D0%B0" title="Википедија:Гласање/Допуна правила о изабраним сликама"u003Eu003Cspan style="color:white"u003EУ току је гласање о допуни правила везаних за изабране слике!u003C/spanu003Eu003C/au003Eu003C/uu003Eu003C/divu003Eu003C/divu003Eu003C/divu003Eu003C/divu003E";());
Etil loflazepat
Иди на навигацију
Иди на претрагу
 | |
 | |
| Klinički podaci | |
|---|---|
| Drugs.com | loflazepate.html Monografija |
| Identifikatori | |
| CAS broj | 29177-84-2  Y |
| ATC kod | None |
| PubChem | CID 3299 |
| DrugBank | DB01545 Y |
| ChemSpider | 3183 Y |
| ChEMBL | CHEMBL1213460 Y |
| Hemijski podaci | |
| Formula | C18H14ClFN2O3 |
| Molarna masa | 360,767 |
SMILES
| |
InChI
| |
| Fizički podaci | |
| Tačka topljenja | 1.935 °C (3.515 °F) |
Etil loflazepat je organsko jedinjenje, koje sadrži 18 atoma ugljenika i ima molekulsku masu od 360,767 Da.[1][2]
Садржај
1 Osobine
2 Reference
3 Literatura
4 Spoljašnje veze
Osobine
| Osobina | Vrednost |
|---|---|
| Broj akceptora vodonika | 4 |
| Broj donora vodonika | 1 |
| Broj rotacionih veza | 4 |
Particioni koeficijent[3] (ALogP) | 3,6 |
Rastvorljivost[4] (logS, log(mol/L)) | -5,8 |
Polarna površina[5] (PSA, Å2) | 67,8 |
Reference
^ Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035—41. PMC 3013709
. PMID 21059682. doi:10.1093/nar/gkq1126.
^ David S. Wishart; Craig Knox; An Chi Guo; Dean Cheng; Savita Shrivastava; Dan Tzur; Bijaya Gautam; Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic acids research. 36 (Database issue): D901—6. PMC 2238889. PMID 18048412. doi:10.1093/nar/gkm958.
^ Ghose, A.K.; Viswanadhan V.N. & Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A. 102: 3762—3772. doi:10.1021/jp980230o.
^ Tetko IV, Tanchuk VY, Kasheva TN, Villa AE (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488—1493. PMID 11749573. doi:10.1021/ci000392t.
^ Ertl P.; Rohde B.; Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714—3717. PMID 11020286. doi:10.1021/jm000942e.
Literatura
.mw-parser-output .refbeginfont-size:90%;margin-bottom:0.5em.mw-parser-output .refbegin-hanging-indents>ullist-style-type:none;margin-left:0.mw-parser-output .refbegin-hanging-indents>ul>li,.mw-parser-output .refbegin-hanging-indents>dl>ddmargin-left:0;padding-left:3.2em;text-indent:-3.2em;list-style:none.mw-parser-output .refbegin-100font-size:100%
Hardman JG, Limbird LE, Gilman AG (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10. изд.). New York: McGraw-Hill. ISBN 0071354697. doi:10.1036/0071422803.
Thomas L. Lemke; David A. Williams, ур. (2007). Foye's Principles of Medicinal Chemistry (6. изд.). Baltimore: Lippincott Willams & Wilkins. ISBN 0781768799.
Spoljašnje veze
 | Etil loflazepat na Vikimedijinoj ostavi. |
- Ethyl loflazepate
Категорије:
- Анксиолитици
- Карбоксилатни естри
- Ацетамиди
- Етри
- Органофлуориди
- Хлороарени
- Бензодиазепини
(RLQ=window.RLQ||[]).push(function()mw.config.set("wgPageParseReport":"limitreport":"cputime":"0.600","walltime":"0.787","ppvisitednodes":"value":3767,"limit":1000000,"ppgeneratednodes":"value":0,"limit":1500000,"postexpandincludesize":"value":93336,"limit":2097152,"templateargumentsize":"value":3764,"limit":2097152,"expansiondepth":"value":17,"limit":40,"expensivefunctioncount":"value":0,"limit":500,"unstrip-depth":"value":0,"limit":20,"unstrip-size":"value":11263,"limit":5000000,"entityaccesscount":"value":1,"limit":400,"timingprofile":["100.00% 697.768 1 -total"," 48.37% 337.486 3 Шаблон:Infobox"," 46.39% 323.721 1 Шаблон:Drugbox-lat"," 23.47% 163.800 1 Шаблон:Reflist"," 18.51% 129.125 1 Шаблон:Commonscat-lat"," 17.42% 121.564 5 Шаблон:Cite_journal"," 16.97% 118.417 4 Шаблон:Cite_pmid"," 7.43% 51.830 1 Шаблон:Cite_pmid/21059682"," 5.58% 38.970 1 Шаблон:Infobox_drug-lat/chemical_formula"," 4.75% 33.126 1 Шаблон:Convert-lat"],"scribunto":"limitreport-timeusage":"value":"0.256","limit":"10.000","limitreport-memusage":"value":5500248,"limit":52428800,"cachereport":"origin":"mw1293","timestamp":"20190428034726","ttl":2592000,"transientcontent":false););"@context":"https://schema.org","@type":"Article","name":"Etil loflazepat","url":"https://sr.wikipedia.org/wiki/Etil_loflazepat","sameAs":"http://www.wikidata.org/entity/Q5404460","mainEntity":"http://www.wikidata.org/entity/Q5404460","author":"@type":"Organization","name":"u0421u0430u0440u0430u0434u043du0438u0446u0438 u043fu0440u043eu0458u0435u043au0430u0442u0430 u0412u0438u043au0438u043cu0435u0434u0438u0458u0435","publisher":"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":"@type":"ImageObject","url":"https://www.wikimedia.org/static/images/wmf-hor-googpub.png","datePublished":"2013-12-14T02:39:36Z","dateModified":"2017-01-04T06:29:34Z","image":"https://upload.wikimedia.org/wikipedia/commons/9/90/Ethyl_loflazepate.svg"(RLQ=window.RLQ||[]).push(function()mw.config.set("wgBackendResponseTime":136,"wgHostname":"mw1269"););
